Pharma has extended protections in the US, past what's reasonable in the rest of the world, in order to keep US companies earning egregious profit margins while putting poor people at risk. On the other hand, software is more global and paying attention to it doesn't focus as much on helping US companies keep monopolies. That's why the US is more concerned with pharma IP protection than the much more widespread theft of IP for software. If it was just IP in general, an important topic and one I support, they would have spent their efforts lambasting Israel's terrible record on software and entertainment IP enforcement.
Indonesia cites faulty component, crew response in last year's AirAsia crash (Reuters)
from the article: Israel may stay on U.S. blacklist in 2007 if it doesn't fix pharma law
Maximum age of patient chaperones who must undergo a security check was raised from 35 to 55, meaning anyone younger than 55 won’t be able to get permission, Palestinians say.10:11 01.12.15 | 0 comments